Soleno Therapeutics, Inc. (SLNO) Tops Q2 EPS by 2c

Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q2 EPS of ($0.57), $0.02 better than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.

You May Also Be Interested In

• Infleqtion raises Q2 revenue to $13.5M after contract restatement
• HSBC Upgrades Blue Star Limited (BLSTR:IN) to Buy
• Bernstein SocGen Group Upgrades Whitbread PLC. (WTB:LN) (WTBCF) to Market Perform